Portfolio: Endo Stops Work on Bladder Cancer Drug

Published January 2, 2013

Portfolio: Endo stops work on bladder cancer drug

Filed under: residential drug treatment centers

The trial, a randomized, active-controlled, open-label, multi-center study, was designed to compare Urocidin with mitomycin C in the treatment of patients with certain types of bladder cancer. The trial was not recruiting at the expected rate and …
Read more on Daily Local News

A Call to Eliminate 'Chemotherapy Concession'

Filed under: residential drug treatment centers

… Chemotherapy-Induced Oral Mucositis · Drug-Induced Pulmonary Toxicity. A new study confirms that financial incentives exist for some US oncologists in the prescribing of chemotherapy and growth factors for treatment-related anemia. … "Specialty …
Read more on Medscape

HIV/AIDS Anti-Diarrheal Drug Fulyzaq (Crofelemer) Approved By FDA

Filed under: residential drug treatment centers

Veregen (sinecatechins), for the treatment of external genital perianal warts, was approved in 2006 and was the first botanical prescription drug to enter the US market. Julie Beitz, M.D., director of the Office of Drug Evaluation III in FDA's Center …
Read more on Medical News Today